CT attenuation of normal liver parenchyma on delayed scanning with iohexol

G Tidebrant1, P Lukes, A Wihed

  • 1Department of Radiology, Ostra Sjukhuset, University of Gothenburg, Sweden.

Insights

Iohexol, an iodine-based contrast agent, is suitable for delayed liver CT scans. This study found increased liver parenchyma attenuation after iohexol administration, indicating its effectiveness.

Area of Science:

  • Radiology
  • Medical Imaging
  • Hepatology

Background:

  • Contrast-enhanced computed tomography (CT) is crucial for liver imaging.
  • Optimizing contrast agents for delayed phase imaging can improve diagnostic accuracy.

Purpose of the Study:

  • To evaluate the suitability of iohexol as a contrast medium for delayed liver CT scanning.
  • To assess the attenuation values of normal liver parenchyma after iohexol administration.

Main Methods:

  • Twenty patients underwent liver CT scans before, during, and 4-6 hours after intravenous iohexol injection.
  • Attenuation of normal liver parenchyma was measured in Hounsfield Units (HU).

Main Results:

  • Mean liver parenchyma attenuation was 62.6 HU on nonenhanced scans.
  • Mean liver parenchyma attenuation increased to 78.7 HU on delayed scans.

Conclusions:

  • Iohexol demonstrates potential as an effective contrast medium for delayed liver CT imaging.
  • The observed increase in attenuation suggests iohexol provides adequate contrast for delayed liver visualization.

Related Concept Videos